Literature DB >> 2952415

Comparison of oral glucose loading and intravenous glucagon injection as stimuli to C-peptide secretion in normal men.

M Small, H N Cohen, G H Beastall, A C MacCuish.   

Abstract

In 10 healthy men, we have compared the respective effects of an intravenous injection of glucagon (1 mg) and an oral glucose load (75 G) in eliciting the release of C-peptide and insulin from the pancreas. Serum C-peptide and insulin concentrations increased respectively to median values of 190% and 500% at 6 minutes after glucagon injection, and 344% and 794% at 30 minutes and 268% and 278% at 60 minutes following glucose ingestion. The oral glucose load was as effective as glucagon injection in testing beta cell function and was free from the unpleasant side effects (nausea, vomiting, syncope) commonly associated with glucagon. We conclude that oral glucose loading is probably the test of choice to elicit C-peptide release when screening populations of normal subjects for adequacy of beta cell function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2952415     DOI: 10.1111/j.1464-5491.1985.tb00630.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  3 in total

1.  Disturbances of insulin in British Asian and white men.

Authors: 
Journal:  BMJ       Date:  1989-10-07

2.  Glycosylated haemoglobin and glucose intolerance in cystic fibrosis.

Authors:  P R Stutchfield; S O'Halloran; J D Teale; D Isherwood; C S Smith; D Heaf
Journal:  Arch Dis Child       Date:  1987-08       Impact factor: 3.791

3.  A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy.

Authors:  Ryosuke Desaki; Shugo Mizuno; Akihiro Tanemura; Masashi Kishiwada; Yasuhiro Murata; Yoshinori Azumi; Naohisa Kuriyama; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Shuji Isaji
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.